ISRGNASDAQ— Intuitive Surgical Inc Price & Analysis

Intuitive Surgical Inc

HEALTHCARE — MEDICAL INSTRUMENTS & SUPPLIES

$452.29

+$8.44+1.90%

Market Cap: $156.80B; Large Cap
P/E Ratio: 53.67; Fwd: 33.33
EPS (TTM): $8.27
Div. Yield: N/A

Technical Summary

RSI (14)70.84Overbought

SMA (50)$396.06Bullish

SMA (200)$436.21Bullish

MACD13.3887Bullish

Bollinger$391.52 – $449.66Upper

Stochastic88.38Overbought

Theo Outlook

Intuitive Surgical develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. For the trailing twelve months it reported revenue of $11.58 billion, a profit margin of 25.5 percent, and earnings per share of $8.27. Its market value stood at $156.80 billion as of the latest quarter ending September 30, 2026.

Bull case: Revenue grew 21.7 percent year over year in the latest quarter while return on equity reached 17.9 percent. Bear case: Quarterly earnings fell 23.6 percent year over year and the trailing price-to-earnings ratio stands at 53.67.

Main risks center on the forward price-to-earnings ratio of 33.33 and beta of 1.463. Analysis generated by HeyTheo AI from company and market data. It may be incomplete or inaccurate.

Analysis generated by HeyTheo AI on Oct 23, 2026.

Company Overview

Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.

Fundamental Snapshot

Revenue: $11.58B
EBITDA: $4.12B
Gross Profit: $7.78B
Operating Margin: 19.4%
Profit Margin: 25.5%
ROE: 17.9%
Book Value: $46.18
Beta: 1.46
52-Wk High: $603.88
52-Wk Low: $328.57
Volume: 2.99M
PEG Ratio: 1.87

Frequently Asked Questions

What does Intuitive Surgical do?

Intuitive Surgical develops, manufactures, and markets robotic products for minimally invasive surgery, most notably the da Vinci Surgical System. The company operates in the healthcare sector under the medical instruments and supplies industry. Its latest quarter ended September 30, 2026.

Where does Intuitive Surgical's revenue come from?

Intuitive Surgical generates revenue from its medical instruments and supplies business in the healthcare sector. Trailing twelve months revenue reached $11.58 billion as of the latest reported period. No further breakdown of revenue sources appears in the data.

How does Intuitive Surgical compete?

Intuitive Surgical competes through its focus on robotic systems for minimally invasive procedures. Its trailing twelve months operating margin stood at 19.4 percent and return on assets at 10.6 percent. The company reported a beta of 1.463 as of the latest data.

What are the main risks for Intuitive Surgical?

Main risks include quarterly earnings that declined 23.6 percent year over year in the latest period. The trailing price-to-earnings ratio of 53.67 and forward price-to-earnings ratio of 33.33 reflect elevated valuation multiples. Beta of 1.463 indicates above-average market volatility as of the latest figures.

How is Intuitive Surgical valued?

Intuitive Surgical trades at a trailing price-to-earnings ratio of 53.67 and a forward price-to-earnings ratio of 33.33. Its price-to-sales ratio is 13.54 and price-to-book ratio is 7.82 based on the latest data. Enterprise value to revenue stands at 12.4 and enterprise value to EBITDA at 32.23.